- Home
- ODD vs PCVX Comparison
ODD vs PCVX Comparison
Compare ODD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODD
- PCVX
- Stock Information
- Founded
- ODD 2018
- PCVX 2013
- Country
- ODD Israel
- PCVX United States
- Employees
- ODD N/A
- PCVX N/A
- Industry
- ODD
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ODD
- PCVX Health Care
- Exchange
- ODD Nasdaq
- PCVX Nasdaq
- Market Cap
- ODD 3.8B
- PCVX 4.0B
- IPO Year
- ODD 2023
- PCVX 2020
- Fundamental
- Price
- ODD $40.34
- PCVX $45.66
- Analyst Decision
- ODD Buy
- PCVX Strong Buy
- Analyst Count
- ODD 11
- PCVX 7
- Target Price
- ODD $75.36
- PCVX $101.67
- AVG Volume (30 Days)
- ODD 846.3K
- PCVX 1.4M
- Earning Date
- ODD 11-19-2025
- PCVX 11-04-2025
- Dividend Yield
- ODD N/A
- PCVX N/A
- EPS Growth
- ODD 25.95
- PCVX N/A
- EPS
- ODD 1.80
- PCVX N/A
- Revenue
- ODD $751,854,000.00
- PCVX N/A
- Revenue This Year
- ODD $25.43
- PCVX N/A
- Revenue Next Year
- ODD $20.18
- PCVX N/A
- P/E Ratio
- ODD $22.22
- PCVX N/A
- Revenue Growth
- ODD 26.12
- PCVX N/A
- 52 Week Low
- ODD $35.30
- PCVX $27.66
- 52 Week High
- ODD $79.18
- PCVX $107.22
- Technical
- Relative Strength Index (RSI)
- ODD 29.58
- PCVX 62.77
- Support Level
- ODD $38.60
- PCVX $40.14
- Resistance Level
- ODD $41.06
- PCVX $45.90
- Average True Range (ATR)
- ODD 2.01
- PCVX 2.15
- MACD
- ODD -0.11
- PCVX -0.10
- Stochastic Oscillator
- ODD 25.21
- PCVX 91.60
About ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.